Report
Iambic Therapeutics shares reportedly jump nearly 18% in trading debut
A post says the Nvidia-backed biotech's $150 million IPO put its market cap just shy of $900 million.
TLDR
A post says Iambic Therapeutics shares rose nearly 18% in their trading debut after the AI-driven cancer drugmaker raised $150 million in its IPO. It says the San Diego biotech plans to use the proceeds to advance three early-stage cancer drug candidates.
Combined views
5.5K
2 Sources, first seen ago
